• Home

  • Documents

  • aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with...
29

aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 2: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 3: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 4: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 5: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 6: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 7: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 8: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 9: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 10: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 11: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 12: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 13: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 14: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 15: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 16: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 17: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 18: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 19: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 20: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 21: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 22: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 23: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 24: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 25: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 26: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 27: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 28: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)
Page 29: aralez.com · 29-01-2015  · COX-2 inhibitor NSAIDs, unless otherwise Indicated. For patients with an increased risk of developing Cardiovascular (C V) and/or Gastrointestinal (GI)

Pharmacology of NSAIDs

Pharmacology of NSAIDs

Health & Medicine
What Are NSAIDs

What Are NSAIDs

Documents
Bleeding and Gastrointestinal Disorders Victory Junction ......bleeding disorder. Forbidden OTCs • NSAIDs and aspirin are contraindicated with a bleeding disorder. Nosebleeds •

Bleeding and Gastrointestinal Disorders Victory Junction ......bleeding disorder. Forbidden OTCs • NSAIDs and aspirin are contraindicated with a bleeding disorder. Nosebleeds •

Documents
NON STEROIDAL ANTI INFLAMMATORY DRUGS. NSAIDS and Geriatrics NSAIDs are the most commonly prescribed drugs worldwide. While NSAIDs are responsible for

NON STEROIDAL ANTI INFLAMMATORY DRUGS. NSAIDS and Geriatrics NSAIDs are the most commonly prescribed drugs worldwide. While NSAIDs are responsible for

Documents
Product Monographheartburn). Prevention of gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs (NSAIDs) in patients with a need for continuous NSAID treatment,

Product Monographheartburn). Prevention of gastrointestinal lesions induced by non-steroidal anti-inflammatory drugs (NSAIDs) in patients with a need for continuous NSAID treatment,

Documents
Chronic NSAIDs Therapy and Upper Gastrointestinal …...7 Chronic NSAIDs Therapy and Upper Gastrointestinal Tract Mechanism of Injury, Mucosal Defense, Risk Factors for Complication

Chronic NSAIDs Therapy and Upper Gastrointestinal …...7 Chronic NSAIDs Therapy and Upper Gastrointestinal Tract Mechanism of Injury, Mucosal Defense, Risk Factors for Complication

Documents
NSAIDS Comparison

NSAIDS Comparison

Documents
NSAIDS (2)

NSAIDS (2)

Documents
CELEBREX , for oral use...•CELEBREX is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. (4, 5.1) •NSAIDs cause an increased risk of serious gastrointestinal

CELEBREX , for oral use...•CELEBREX is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. (4, 5.1) •NSAIDs cause an increased risk of serious gastrointestinal

Documents
NSAIDs and Cardiovascular Drugs in Neurodegenerative and ... Mendel Digna Margarete... · NSAIDs and Cardiovascular Drugs in Neurodegenerative and Cerebrovascular Diseases NSAIDs

NSAIDs and Cardiovascular Drugs in Neurodegenerative and ... Mendel Digna Margarete... · NSAIDs and Cardiovascular Drugs in Neurodegenerative and Cerebrovascular Diseases NSAIDs

Documents
Reference ID: 3928111 - Food and Drug Administration GASTROINTESTINAL EVENTS . See full prescribing information for complete boxed warning. Nonsteroidal anti-inflammatory drugs (NSAIDs)

Reference ID: 3928111 - Food and Drug Administration GASTROINTESTINAL EVENTS . See full prescribing information for complete boxed warning. Nonsteroidal anti-inflammatory drugs (NSAIDs)

Documents
Clinical Nsaids Usage

Clinical Nsaids Usage

Health & Medicine
PHARM4515-16 (NSAIDs)

PHARM4515-16 (NSAIDs)

Documents
Introduction NSAIDS

Introduction NSAIDS

Documents
Ocular nsaids s

Ocular nsaids s

Health & Medicine
Changes in Body Composition Oral and Gastrointestinal Changes · ¡ Antiparkinsonian agents ¡ ¡ NSAIDs ¡ Narcotic analgesics ¡ Antineoplastic agents ¡ CNS depressants ¡ Psychotropics

Changes in Body Composition Oral and Gastrointestinal Changes · ¡ Antiparkinsonian agents ¡ ¡ NSAIDs ¡ Narcotic analgesics ¡ Antineoplastic agents ¡ CNS depressants ¡ Psychotropics

Documents
Antiinflamma and NSAIDs

Antiinflamma and NSAIDs

Documents
Kelompok 3. Enzyme Inhibitor Pengertian ; Inhibitor Inhibitor

Kelompok 3. Enzyme Inhibitor Pengertian ; Inhibitor Inhibitor

Documents
NSAIDs GI Toxicity Dr. N. Aletaha MD NSAIDs NSAIDs are popular because : Analgesic Antipyretic Anti-inflammatory (at higher doses) AspirinAspirin is

NSAIDs GI Toxicity Dr. N. Aletaha MD NSAIDs NSAIDs are popular because : Analgesic Antipyretic Anti-inflammatory (at higher doses) AspirinAspirin is

Documents
Diclofenac in the treatment of osteoarthritis...nonselective oral NSAIDs plus gastroprotec tive agents, or COX2 inhibitors for patients at increased gastrointestinal risk [37]. In

Diclofenac in the treatment of osteoarthritis...nonselective oral NSAIDs plus gastroprotec tive agents, or COX2 inhibitors for patients at increased gastrointestinal risk [37]. In

Documents
Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Gastrointestinal Bleeding 2012. Pathophysiology of GI Bleeding Mucosal lesions – Acid-peptic disease, drug-induced (NSAIDs), Infectious (H. pylori), inflammatory

Documents
NSAIDs - cart.gesa.org.au Guidelines and... · Endorsed september 2009 5 ExEcutIvE summary the third edition of nSAids and the gastrointestinal tract has been updated to help Australian

NSAIDs - cart.gesa.org.au Guidelines and... · Endorsed september 2009 5 ExEcutIvE summary the third edition of nSAids and the gastrointestinal tract has been updated to help Australian

Documents
Nonsteroidal Antiinflammatory Drugs (NSAIDs)Nonsteroidal Antiinflammatory Drugs (NSAIDs) JOHN THEOULAKIS Marketing Director of Info –Pharma P.C. For what conditions are NSAIDs used?

Nonsteroidal Antiinflammatory Drugs (NSAIDs)Nonsteroidal Antiinflammatory Drugs (NSAIDs) JOHN THEOULAKIS Marketing Director of Info –Pharma P.C. For what conditions are NSAIDs used?

Documents
NSAIDs (VK)

NSAIDs (VK)

Education
Nsaids Final 1

Nsaids Final 1

Documents
Acid peptic disease nsaids

Acid peptic disease nsaids

Documents
Chronic NSAIDs Therapy and Upper Gastrointestinal Tract …cdn.intechopen.com/pdfs/35447/InTech-Chronic_nsaids... · 2018-09-25 · 7 Chronic NSAIDs Therapy and Upper Gastrointestinal

Chronic NSAIDs Therapy and Upper Gastrointestinal Tract …cdn.intechopen.com/pdfs/35447/InTech-Chronic_nsaids... · 2018-09-25 · 7 Chronic NSAIDs Therapy and Upper Gastrointestinal

Documents
NSAIDS - Orbit

NSAIDS - Orbit

Documents
The HSP90 Inhibitor, AT13387, Is Effective against …...Preclinical Development The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal

The HSP90 Inhibitor, AT13387, Is Effective against …...Preclinical Development The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal

Documents
NSAIDs 2014

NSAIDs 2014

Health & Medicine